Izadora De Souza
Sao Paulo, SP, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
HMOX1 controls a heme-ferritin switch that protects cells from ferroptosis.
Journal: Science advances
Published: August 19, 2026
Tipping the balance: NRF2's dual role in ferroptotic fate.
Journal: Oncogenesis
Published: February 23, 2026
Riboflavin metabolism shapes FSP1-driven ferroptosis resistance.
Journal: Nature cell biology
Published: February 08, 2025
Temozolomide resistance mechanisms: unveiling the role of translesion DNA polymerase kappa in glioblastoma spheroids in vitro.
Journal: Bioscience reports
Published: December 11, 2023
Temozolomide Resistance in Glioblastoma by NRF2: Protecting the Evil.
Journal: Biomedicines
Published: February 24, 2023
Ferroptosis Modulation: Potential Therapeutic Target for Glioblastoma Treatment.
Journal: International journal of molecular sciences
Published: May 26, 2022
DNA polymerase eta protects human cells against DNA damage induced by the tumor chemotherapeutic temozolomide.
Journal: Mutation research. Genetic toxicology and environmental mutagenesis
Published: November 24, 2021
Revealing Temozolomide Resistance Mechanisms via Genome-Wide CRISPR Libraries.
Journal: Cells
Published: September 25, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026